The Cleveland Cardiometabolic Cohort

Completed

Conditions studied: HIV, Lipodystrophy

In brief

In this observational study, the investigators will examine the changes in body composition in HIV-infected subjects before and after initiation of HIV treatment, and look at the correlations with changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.

Key facts

Study ID

NCT03059121

Run by

University Hospitals Cleveland Medical Center

People needed

56

Starts

2016-09-01

Expected to finish

2025-05-19

Last updated by the study team

2026-01-28

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV-1 infection as documented by any licensed ELISA test kit and confirmed by Western blot at any time prior to study entry. HIV-1 culture, HIV-1 antigen, plasma HIV-1 RNA, or a second antibody test by a method other than ELISA is acceptable as an alternative confirmatory test
• Provides written informed consent and is capable of reading and comprehending the informed consent
• Is not currently taking antiretroviral therapy and has never been on such treatments in the past. Exception would be for subjects who had been in the past on ≤30 days cumulative antiretrovirals, as long as these were stopped >6 months prior to study entry
• Is planning on starting antiretroviral therapy as part of routine clinic care

You may not qualify if…

• Pregnancy or lactation

Where it is running

• University Hospitals Case Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.